Selective Retinoids That Inhibit IKK as Chemotherapeutic Agents Against Estrogen-Independent Breast Cancer Cells
Abstract
We have investigated the effect of novel selective retinoid-related molecules that induce apoptosis in breast cancer cells on IKK/NF kappa B activity. We identified one retinoid antagonist that elicited a strong inhibition of IKK in the ER-negative cell line MDA-MB-468. Other retinoid analogs were not as potent IKK inhibitors in intact cells, although they exerted a significant inhibition of IKK in vitro and a strong inhibition of cell proliferation that correlated with the induction of apoptosis in ER-negative cells. Our data observed in breast cancer cells as well as in cells obtained from other type of human tumors indicate that the inhibition of IKK/NF kappa B activity is critical for the induction of apoptosis by the retinoid antagonist, but not by other retinoid analogs. Our findings with non-retinoid analogs known to inhibit IKK and a non- pharmacological approach to block IKK/NF kappa B signaling, indicate that inhibition of this pathway is sufficient to induce cell death. Therefore, inhibitors of IKK could serve as promising new anticancer agents, either as a stand-alone therapy or in combination therapies with other anticancer approaches. In this respect, it is noteworthy that inhibitors of IKK sensitize tumor cells to the anticancer activity of certain chemotherapeutic drugs.
Document Details
- Document Type
- Technical Report
- Publication Date
- Aug 01, 2002
- Accession Number
- ADA409402
Entities
People
- Francisco J. Piedraftia